RKDA Arcadia Biosciences, Inc.: institutional ownership and insider trading
17 funds reported holding $173K of Arcadia Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $93.6K, with 8 new positions and 7 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding RKDA
- Ken Griffin (Citadel Advisors): $16.1K, 0.0% of the portfolio
Largest institutional holders of RKDA
- HRT FINANCIAL LP — $60.0K
- VANGUARD GROUP INC — $27.8K
- CITADEL ADVISORS LLC — $16.1K
- Virtu Financial LLC — $15.0K
- StoneX Group Inc. (SNEX) — $11.3K
- GEODE CAPITAL MANAGEMENT, LLC — $11.0K
- XTX Topco Ltd — $10.5K
- STATE STREET CORP (STT, STT-PG) — $8.25K
- JANE STREET GROUP, LLC — $6.96K
- VANGUARD CAPITAL MANAGEMENT LLC — $6.55K
Recent RKDA insider trades
- Feb 3, 2025: Kawakami Mark bought 700 shares ($1.74K)
- Feb 3, 2025: Schaefer Thomas J. bought 700 shares ($1.74K)
5%+ owners
- MJL Manager LLC: 15.7% (Schedule 13G, filed Sep 30, 2026)
- Armistice Capital, LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)